Jackson Square Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.5M Buy
+43,545
New +$3.89M 0.63% 36
2024
Q2
Sell
-9,280
Closed -$740K 134
2024
Q1
$740K Sell
9,280
-1,212
-12% -$92.6K 0.19% 89
2023
Q4
$828K Buy
+10,492
New +$747K 0.27% 72
2023
Q1
Sell
-17,094
Closed -$1.59M 115
2022
Q4
$1.59M Sell
17,094
-961
-5% -$92.7K 0.75% 39
2022
Q3
$1.72M Sell
18,055
-584
-3% -$57.8K 0.84% 34
2022
Q2
$1.73M Sell
18,639
-248
-1% -$24.2K 0.73% 41
2022
Q1
$1.91M Buy
18,887
+545
+3% +$57.3K 0.6% 54
2021
Q4
$1.89M Buy
18,342
+12,064
+192% +$1.11M 0.54% 53
2021
Q3
$533K Buy
6,278
+1,926
+44% +$161K 0.17% 108
2021
Q2
$363K Buy
4,352
+431
+11% +$35.3K 0.12% 142
2021
Q1
$295K Buy
3,921
+309
+9% +$22.5K 0.11% 142
2020
Q4
$247K Sell
3,612
-80
-2% -$5.2K 0.1% 136
2020
Q3
$216K Buy
3,692
+2,551
+224% +$159K 0.1% 125
2020
Q2
$74K Buy
1,141
+412
+57% +$25.9K 0.04% 148
2020
Q1
$43K Buy
729
+640
+719% +$42.7K 0.03% 130
2019
Q4
$7K Buy
+89
New +$6.25K ﹤0.01% 275

Other funds holding CVS

Jackson Square Capital's CVS Position: Q2 2026 in Review

Jackson Square Capital opened a new position in CVS Health (CVS) in Q2 2026: 43,545 shares worth $4.5M. The stake represents 0.63% of the portfolio and ranks #36 among its holdings. This is a return to the name: Jackson Square Capital previously reported a position in CVS as recently as Q1 2024.

Jackson Square Capital first reported a position in CVS in Q4 2019 and has held it in 16 quarters since. 567 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Jackson Square Capital held 43,545 shares of CVS Health worth $4.5M as of Q2 2026.
  • CVS Health was a new Jackson Square Capital position in Q2 2026.
  • CVS Health made up 0.63% of Jackson Square Capital's portfolio in Q2 2026, its #36 holding.
  • Jackson Square Capital first reported a position in CVS Health in Q4 2019 and has held it in 16 quarters since.
  • 567 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.